Registered entities
TAYSHA GENE THERAPIES, INC.
Reg. No. 1806310United States
Social engagement
Social engagement: 21.4K social following, 10 posts in the last 12 months — around the industry typical range.
Investor mix
22 investors on record; lead investors include PBM Capital, Nolan Capital, Fidelity Investments; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 45% |
| Private equity | 4 | 18% |
| Bank & private debt | 1 | 5% |
| Other / undisclosed | 7 | 32% |
Hiring activity
No recent openings observed
No roles tracked in the last 12 months
16 Oct 2024 · Director, Global Patient Safety & Pharmacovigilance Operations · null
Based on job postings tracked across public sources.
Recent activity
26 Jun 2026
Event
International Rett Syndrome Foundation ASCEND 2026 Rett Syndrome National Summit
25 Jun 2026
Event
2026 International Rett Syndrome Foundation (IRSF) Rett Syndrome Scientific Meeting
22 Jun 2026
Milestone
regulatory